PLX
Protalix Biotherapeutics Inc
NYSE MKT: PLX · HEALTHCARE · BIOTECHNOLOGY
$2.02
+3.06% today
Updated 2026-05-06
Market cap
$170.81M
P/E ratio
—
P/S ratio
3.24x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
Protalix Biotherapeutics Inc (PLX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $150000.00 | — | — | $388000.00 | $11.24M | $8.39M | $34.42M | $11.51M | $15.16M | $4.36M | $9.20M | $21.08M | $34.24M | $54.69M | $62.90M | $38.35M | $47.64M | $65.49M | $53.40M | $52.74M |
| Revenue growth (YoY) | — | -100.0% | — | — | +2797.9% | -25.4% | +310.5% | -66.6% | +31.7% | -71.2% | +110.8% | +129.1% | +62.4% | +59.7% | +15.0% | -39.0% | +24.2% | +37.5% | -18.5% | -1.2% |
| Cost of revenue | $35000.00 | $2.25M | — | $3.58M | $4.38M | $1.52M | $8.14M | $5.43M | $9.05M | $730000.00 | $8.40M | $15.23M | $9.30M | $10.89M | $10.87M | $16.35M | $19.59M | $22.98M | $24.32M | $26.99M |
| Gross profit | $115000.00 | — | — | $-3.19M | $6.86M | $1.44M | $26.28M | $6.08M | $6.11M | $3.63M | $801000.00 | $5.85M | $24.94M | $43.80M | $52.02M | $22.00M | $28.05M | $42.51M | $29.08M | $25.75M |
| Gross margin | 76.7% | — | — | -821.4% | 61.0% | 17.2% | 76.3% | 52.9% | 40.3% | 83.3% | 8.7% | 27.7% | 72.8% | 80.1% | 82.7% | 57.4% | 58.9% | 64.9% | 54.5% | 48.8% |
| R&D | $5.25M | $12.86M | $17.40M | $21.64M | $29.95M | $31.04M | $28.69M | $29.23M | $27.35M | $20.02M | $30.41M | $28.83M | $33.33M | $44.62M | $38.17M | $29.73M | $29.35M | $17.09M | $12.97M | $19.57M |
| SG&A | $4.53M | $11.71M | $6.77M | $7.14M | $6.88M | $6.93M | $9.76M | $8.38M | $9.66M | $7.28M | $9.36M | $11.53M | $1.94M | $5.97M | $5.09M | $4.02M | $-13.58M | $25.46M | $40.79M | $11.68M |
| Operating income | $-9.70M | $-24.57M | $-24.17M | $-31.97M | $-29.97M | $-36.53M | $-12.17M | $-27.12M | $-28.56M | $-23.67M | $-33.16M | $-34.52M | $-19.31M | $-10.72M | $2.71M | $-20.46M | $-13.01M | $10.46M | $3.92M | $-5.50M |
| Operating margin | -6469.3% | — | — | -8239.4% | -266.5% | -435.6% | -35.4% | -235.5% | -188.4% | -542.4% | -360.5% | -163.8% | -56.4% | -19.6% | 4.3% | -53.4% | -27.3% | 16.0% | 7.3% | -10.4% |
| EBITDA | $-8.99M | $-21.79M | $-21.18M | $-29.98M | $-26.83M | $-32.90M | $-7.93M | $-23.58M | $-25.22M | $-21.18M | $-23.00M | $-71.80M | $-17.10M | $-8.69M | $4.45M | $-18.94M | $-10.78M | $12.94M | $6.52M | $-4.04M |
| EBITDA margin | -5994.7% | — | — | -7726.5% | -238.6% | -392.3% | -23.0% | -204.8% | -166.4% | -485.3% | -250.0% | -340.6% | -49.9% | -15.9% | 7.1% | -49.4% | -22.6% | 19.8% | 12.2% | -7.7% |
| EBIT | $-9.43M | $-22.48M | $-22.41M | $-31.97M | $-29.92M | $-36.53M | $-11.62M | $-27.12M | $-28.36M | $-23.55M | $-24.98M | $-73.72M | $-18.77M | $-10.31M | $3.15M | $-20.06M | $-11.87M | $11.75M | $5.22M | $-5.50M |
| Interest expense | $0.00 | $0.00 | $0.00 | $529000.00 | $968000.00 | $2000.00 | $34000.00 | $674000.00 | $4.93M | $3.73M | $4.19M | $9.72M | $7.68M | $7.97M | $9.67M | $7.52M | $2.53M | $3.18M | $1.06M | $1.19M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.43M | $-22.48M | $-22.41M | $-31.44M | $-29.00M | $-36.53M | $-11.62M | $-27.79M | $-29.94M | $58.04M | $-29.36M | $-83.44M | $-26.46M | $-18.28M | $-6.52M | $-27.58M | $-14.93M | $8.31M | $2.93M | $-6.60M |
| Net income growth (YoY) | — | -138.5% | +0.3% | -40.3% | +7.8% | -26.0% | +68.2% | -139.2% | -7.7% | +293.8% | -150.6% | -184.1% | +68.3% | +30.9% | +64.3% | -322.8% | +45.9% | +155.7% | -64.7% | -325.2% |
| Profit margin | -6284.7% | — | — | -8103.1% | -257.9% | -435.6% | -33.7% | -241.4% | -197.5% | 1329.9% | -319.2% | -395.9% | -77.3% | -33.4% | -10.4% | -71.9% | -31.3% | 12.7% | 5.5% | -12.5% |